Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

A man regrew hair after using a 2% fluorouracil treatment on his scalp.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Combining fractional laser with minoxidil 5% is more effective for treating male hair loss than using minoxidil 5% alone.

Low-energy fractional CO2 laser therapy significantly improves hair regrowth in women with female-pattern hair loss.

Flutamide emulgel with 1% Transcutol P absorbs better through the skin than other mixtures.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Doping in football faces legal challenges with testosterone limits, hair loss treatments, and recreational drug use.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

AC5 improves hair loss and hair quality with high satisfaction rates.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

A hair growth ointment improved hair length in a family with a genetic hair growth condition.

Tofacitinib significantly improved skin and hair conditions without side effects.

CD2 might be a new treatment target for patchy alopecia areata.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Careful patient selection is crucial for safe and effective fractional CO2 laser therapy.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib might be used to treat hair loss.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.